Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 98
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

The fate of mitochondrial respiratory complexes in aging

The fate of mitochondrial respiratory complexes in aging

 115

Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency

Fully biologic endothelialized-tissue-engineered vascul...

 68

Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition

Loss of p300 in proximal tubular cells reduces renal fi...

 80